These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9051843)

  • 21. Systemic absorption of 5-fluorouracil during vitrectomy.
    Creten O; Spileers W; Stalmans P
    Am J Ophthalmol; 2006 Jul; 142(1):194-6. PubMed ID: 16815286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.
    Oshima Y; Wakabayashi T; Sato T; Ohji M; Tano Y
    Ophthalmology; 2010 Jan; 117(1):93-102.e2. PubMed ID: 19880185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.
    Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ
    Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated adrenomedullin in the vitreous of patients with proliferative vitreoretinopathy.
    Udono T; Takahashi K; Takano S; Shibahara S; Tamai M
    Am J Ophthalmol; 1999 Dec; 128(6):765-7. PubMed ID: 10612519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitrectomy for proliferative diabetic retinopathy with asteroid hyalosis.
    Ikeda T; Sawa H; Koizumi K; Yasuhara T; Kinoshita S; Tano Y
    Retina; 1998; 18(5):410-4. PubMed ID: 9801034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy.
    Honkanen RA; Baruah S; Zimmerman MB; Khanna CL; Weaver YK; Narkiewicz J; Waziri R; Gehrs KM; Weingeist TA; Boldt HC; Folk JC; Russell SR; Kwon YH
    Arch Ophthalmol; 2003 Feb; 121(2):183-8. PubMed ID: 12583783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High infusion pressure in conjunction with vitreous surgery alters the morphology and function of the retina of rabbits.
    Minami M; Oku H; Okuno T; Fukuhara M; Ikeda T
    Acta Ophthalmol Scand; 2007 Sep; 85(6):633-9. PubMed ID: 17403020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new curved vitreous cutter for managing phakic retinal detachment with proliferative vitreoretinopathy.
    Natarajan S; Malpani A; Nirmalan PK
    Indian J Ophthalmol; 1998 Jun; 46(2):87-9. PubMed ID: 9847480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy.
    González-Avila G; Lozano D; Manjarrez ME; Ruiz VM; Terán L; Vadillo-Ortega F; Selman M
    Ophthalmology; 1995 Sep; 102(9):1400-5. PubMed ID: 9097780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electron microscopical and chemical investigations of the pathological changes of the vitreous body].
    Klemen UM
    Doc Ophthalmol; 1981 Mar; 51(1-2):113-43. PubMed ID: 6972859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of glutamine concentration in the vitreous humor in patients with proliferative vitreoretinopathy.
    Ishikawa S; Nakazawa M; Ishikawa A; Ishiguro S; Tamai M
    Curr Eye Res; 1995 Mar; 14(3):191-7. PubMed ID: 7796602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An endoscopic overview of the anterior vitreous base in retinal detachment and anterior proliferative vitreoretinopathy.
    Boscher C; Kuhn F
    Acta Ophthalmol; 2014 Jun; 92(4):e298-304. PubMed ID: 24428936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative vitreoretinopathy: cytologic findings in vitreous samples.
    Martín F; Pastor JC; De La Rúa ER; Mayo-Iscar A; García-Arumí J; Martínez V; Fernández N; Saornil MA
    Ophthalmic Res; 2003; 35(4):232-8. PubMed ID: 12815199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.
    Kuo HK; Chen YH; Huang F; Wu YC; Shiea J; Wu PC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):205-13. PubMed ID: 25940552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of flow cytometry with the surgeon regarding ability to predict the ultimate success of surgery for proliferative vitreoretinopathy.
    Cousins SW; Rubsamen PE
    Arch Ophthalmol; 1994 Dec; 112(12):1554-60. PubMed ID: 7993210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.
    Banerjee S; Savant V; Scott RA; Curnow SJ; Wallace GR; Murray PI
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2203-7. PubMed ID: 17460280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial characterization of a putative new growth factor present in pathological human vitreous.
    Pombo C; Bokser L; Casabiell X; Zugaza J; Capeans M; Salorio M; Casanueva F
    Graefes Arch Clin Exp Ophthalmol; 1996 Mar; 234(3):155-63. PubMed ID: 8720714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.